Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sarepta Therapeutics, Inc.SRPT · Entity 4426 | Chief Financial Officer | September 04, 2026 | September 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sarepta Therapeutics, Inc.
Report date September 04, 2026 · Filed September 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 121,792 |
Reported balance
After 2026-09-04 transaction · row 1
1 source rowRow 1 · 2026-09-04 · Tax withholding · Disposed 13,272 · Balance 121,792 F1: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2026 Filed Sep 9, 2026 00:05 UTC | Sarepta Therapeutics, Inc. SRPT · Entity 4426 | Tax withholdingCommon Stock | 13,272 | $22.22 | $294,903.84 |
DisclosureSEC source: 0001193125-26-385545 · ownership.xml · nonDerivative · entry 1 Wong Ryan Ho-Yan · CIK 0002079673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,792 F1 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025. Read SEC document |
| March 11, 2026 Filed Mar 14, 2026 00:07 UTC | Sarepta Therapeutics, Inc. SRPT · Entity 4426 | Tax withholdingCommon Stock | 256 | $17.03 | $4,359.68 |
DisclosureSEC source: 0001193125-26-106706 · ownership.xml · nonDerivative · entry 1 Wong Ryan Ho-Yan · CIK 0002079673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,064 F1 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 10, 2025. Read SEC document |
| March 09, 2026 Filed Mar 12, 2026 00:08 UTC | Sarepta Therapeutics, Inc. SRPT · Entity 4426 | Tax withholdingCommon Stock | 113 | $16.95 | $1,915.35 |
DisclosureSEC source: 0001193125-26-102710 · ownership.xml · nonDerivative · entry 2 Wong Ryan Ho-Yan · CIK 0002079673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,320 F2 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023. Read SEC document |
| March 09, 2026 Filed Mar 12, 2026 00:08 UTC | Sarepta Therapeutics, Inc. SRPT · Entity 4426 | Tax withholdingCommon Stock | 162 | $16.95 | $2,745.90 |
DisclosureSEC source: 0001193125-26-102710 · ownership.xml · nonDerivative · entry 1 Wong Ryan Ho-Yan · CIK 0002079673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,433 F1 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 01:05 UTC | Sarepta Therapeutics, Inc. SRPT · Entity 4426 | Tax withholdingCommon Stock | 450 | $16.20 | $7,290.00 |
DisclosureSEC source: 0001193125-26-089433 · ownership.xml · nonDerivative · entry 1 Wong Ryan Ho-Yan · CIK 0002079673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,595 F1 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024. Read SEC document |
| December 01, 2025 Filed Dec 11, 2025 01:05 UTC | Sarepta Therapeutics, Inc. SRPT · Entity 4426 | Tax withholdingCommon Stock | 78 | $20.96 | $1,634.88 |
DisclosureSEC source: 0001193125-25-314652 · ownership.xml · nonDerivative · entry 2 Wong Ryan Ho-Yan · CIK 0002079673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,045 F2 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 30, 2022. Read SEC document |
| December 01, 2025 Filed Dec 11, 2025 01:05 UTC | Sarepta Therapeutics, Inc. SRPT · Entity 4426 | Tax withholdingCommon Stock | 80 | $20.96 | $1,676.80 |
DisclosureSEC source: 0001193125-25-314652 · ownership.xml · nonDerivative · entry 1 Wong Ryan Ho-Yan · CIK 0002079673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,123 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 30, 2021. Read SEC document |
| September 03, 2025 Filed Sep 6, 2025 01:30 UTC | Sarepta Therapeutics, Inc. SRPT · Entity 4426 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-197424 · ownership.xml · nonDerivative · entry 2 Wong Ryan Ho-Yan · CIK 0002079673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,203 F2 · shares: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board. Read SEC document |
| September 03, 2025 Filed Sep 6, 2025 01:30 UTC | Sarepta Therapeutics, Inc. SRPT · Entity 4426 | GrantCommon Stock | 93,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-197424 · ownership.xml · nonDerivative · entry 1 Wong Ryan Ho-Yan · CIK 0002079673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,203 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company. Read SEC document |
| July 31, 2025 Filed Aug 5, 2025 00:10 UTC | Sarepta Therapeutics, Inc. SRPT · Entity 4426 | Tax withholdingCommon Stock | 327 | $16.42 | $5,369.34 |
DisclosureSEC source: 0000950170-25-102279 · ownership.xml · nonDerivative · entry 1 Wong Ryan Ho-Yan · CIK 0002079673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,328 F1 · shares: Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on July 30, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.